TIAA CREF Investment Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$45.1M Buy
310,779
+111,076
+56% +$14.6M 0.03% 430
2018
Q4
$22.6M Buy
199,703
+5,841
+3% +$731K 0.02% 609
2018
Q3
$26.1M Buy
193,862
+9,749
+5% +$1.2M 0.02% 633
2018
Q2
$20.7M Buy
184,113
+3,593
+2% +$388K 0.01% 723
2018
Q1
$19.3M Sell
180,520
-140,972
-44% -$15.2M 0.01% 778
2017
Q4
$35.2M Sell
321,492
-44,099
-12% -$4.8M 0.02% 553
2017
Q3
$39.5M Buy
365,591
+53,942
+17% +$5.54M 0.03% 516
2017
Q2
$31.5M Sell
311,649
-60,714
-16% -$5.59M 0.02% 578
2017
Q1
$33.5M Sell
372,363
-8,955
-2% -$761K 0.02% 561
2016
Q4
$29.1M Buy
381,318
+134,301
+54% +$10.2M 0.02% 610
2016
Q3
$20.6K Sell
247,017
-160,084
-39% -$13.4M 0.01% 762
2016
Q2
$33.6M Buy
407,101
+94,180
+30% +$7.76M 0.03% 549
2016
Q1
$23.8M Buy
312,921
+51,097
+20% +$3.78M 0.02% 682
2015
Q4
$21M Buy
261,824
+39,173
+18% +$2.83M 0.02% 738
2015
Q3
$14.1M Buy
222,651
+59,960
+37% +$4.31M 0.01% 868
2015
Q2
$11.4M Sell
162,691
-82,547
-34% -$6.11M 0.01% 1059
2015
Q1
$19.4M Buy
245,238
+96,144
+64% +$7.09M 0.01% 792
2014
Q4
$9.49M Buy
149,094
+48,483
+48% +$3.04M 0.01% 1147
2014
Q3
$6.01M Sell
100,611
-175,956
-64% -$10.1M ﹤0.01% 1474
2014
Q2
$14.8M Sell
276,567
-44,520
-14% -$2.44M 0.01% 921
2014
Q1
$19.4M Buy
321,087
+35,435
+12% +$2.07M 0.01% 808
2013
Q4
$15.2M Buy
285,652
+82,451
+41% +$4.14M 0.01% 913
2013
Q3
$9.4M Buy
203,201
+100,122
+97% +$4.59M 0.01% 1126
2013
Q2
$4.23M Buy
+103,079
New +$4.42M ﹤0.01% 1647

Other funds holding CRL